NCT02817620View on ClinicalTrials.gov

Study to Assess Antioxidant Efficacy of Spirulina on oxLDL and Lipids Metabolism on Subjects With Metabolic Syndrome

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 24, 2016

Primary Completion Date

September 14, 2017

Study Completion Date

September 14, 2017

Conditions
Metabolic Syndrome
Interventions
DIETARY_SUPPLEMENT

Spirulysat®

DIETARY_SUPPLEMENT

Placebo

Trial Locations (1)

44800

Biofortis Mérieux NutriSciences Clinical Investigation Center, Saint-Herblain

All Listed Sponsors
collaborator

Biofortis Mérieux NutriSciences

OTHER

lead

Algosource

INDUSTRY

NCT02817620 - Study to Assess Antioxidant Efficacy of Spirulina on oxLDL and Lipids Metabolism on Subjects With Metabolic Syndrome | Biotech Hunter | Biotech Hunter